Healthcare / Healthcare PlansNSE
$366.95
-0.60 (-0.16%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $621.5M · quality 76.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
46/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$27.4B
P/E
30.3x
↑EV/EBITDA
14.8x
↑ROE
10.5%
↑Gross Margin
56.4%
↑Debt/Equity
0.06
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
+21.7%
FCF CAGR
+5.2%
FCF margin
6.9%
FCF / Net income
0.71x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $9.05B · net income $878.9M · FCF $621.5M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $9.05B | $9.05B | $7.23B | $6.33B | $5.02B |
| Net Income | $878.9M | $878.9M | $908.8M | $669.4M | $740.6M |
| EBITDA | $1.79B | $1.79B | $1.78B | $1.31B | $1.33B |
| EPS | 12.14 | 12.14 | 12.85 | 9.53 | 10.76 |
| Gross Margin | 56.4% | 56.4% | 57.7% | 88.9% | 87.8% |
| Operating Margin | 10.8% | 10.8% | 13.6% | 16.3% | 18.8% |
| Net Margin | 9.7% | 9.7% | 12.6% | 10.6% | 14.7% |
| Balance Sheet | |||||
| Debt/Equity | 0.06 | 0.06 | 0.38 | 0.06 | 0.08 |
| Current Ratio | 1.34 | 1.34 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $621.5M | $621.5M | $922.9M | $479.6M | $534.1M |
| Returns | |||||
| ROE | 10.5% | 10.5% | 16.8% | 14.2% | 19.7% |
| Valuation | |||||
| P/E | 30.25 | 30.25 | 36.44 | 58.40 | — |
| EV/EBITDA | 14.85 | 14.85 | 19.29 | 29.73 | — |
| P/B | 3.17 | 3.17 | 6.12 | 8.28 | — |
| Growth & Yield | |||||
| Revenue Growth | 25.1% | 25.1% | 14.2% | 26.1% | — |
| EPS Growth | -5.5% | -5.5% | 34.8% | -11.4% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
38.9%
EPS terminal req.
$32.56
Spread vs growth
-44.5%
5Y implied EPS CAGR
26.5%
EPS terminal req.
$39.40
Spread vs growth
-32.1%
10Y implied EPS CAGR
18.0%
EPS terminal req.
$63.45
Spread vs growth
-23.5%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-28.5%
Start / end P/E
39.9x → 30.2x
EPS bridge
12.85 → 12.14
Residual
+1.3%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.